Journals / Solunum / 2014 / Cilt: 16 - Sayı: 1

Infective Exacerbations of Chronic Obstructive Pulmonary Disease with or without Pneumonia

Journal
Solunum
Pages
31–35
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Among laboratory findings, whilst there was no difference between the groups in terms of C-reactive protein (CRP), lactate dehydrogenase (LDH) and leukocyte counts, it was observed that forced expiratory volume in 1 second (FEV1) (33.5±10% versus 55±19%; p<0.05 ) was lower in the exacerbation group without pneumonia.Conclusion: It is concluded that COPD patients who were more serious cigarette addicts, had a lower forced expiratory volume in 1 second (FEV1) and a longer disease duration are more prone to exacerbations without pneumonia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It was aimed to evaluate the relation between the presence of pneumonia and clinical, demographic and biochemical data of patients with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) during exacerbation in case-control groups.Methods: The present study, which was designed as a prospective study, included COPD cases with or without pneumonia diagnosis, hospitalized between 2007 and 2008 in a tertiary chest diseases clinic for acute exacerbation.
📊
Key Findings & Data:Patients that were diagnosed with pneumonia based on clinical and radiological findings at the time of hospitalization were assigned to the pneumonic exacerbation (PE) group and the cases without significant infiltration were assigned to the non-pneumonic exacerbation (n-PE) group.
💡
Conclusion & Impact:Among laboratory findings, whilst there was no difference between the groups in terms of C-reactive protein (CRP), lactate dehydrogenase (LDH) and leukocyte counts, it was observed that forced expiratory volume in 1 second (FEV1) (33.5±10% versus 55±19%; p<0.05 ) was lower in the exacerbation group without pneumonia.Conclusion: It is concluded that COPD patients who were more serious cigarette addicts, had a lower forced expiratory volume in 1 second (FEV1) and a longer disease duration are more prone to exacerbations without pneumonia.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: It was aimed to evaluate the relation between the presence of pneumonia and clinical, demographic and biochemical data of patients with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) during exacerbation in case-control groups.Methods: The present study, which was designed as a prospective study, included COPD cases with or without pneumonia diagnosis, hospitalized between 2007 and 2008 in a tertiary chest diseases clinic for acute exacerbation. Patients that were diagnosed with pneumonia based on clinical and radiological findings at the time of hospitalization were assigned to the pneumonic exacerbation (PE) group and the cases without significant infiltration were assigned to the non-pneumonic exacerbation (n-PE) group. All patients were investigated in terms of demographic and biochemical data, as well as pulmonary function tests and time to exacerbation. Data were compared using chi-square test for categorical variables and student t-test for parametric variables, and a p <0.05 was considered significant. Relation between variables was analysed by Pearson correlation test.Results: The study included 30 patients (23 males and 7 females; mean age±SD:69±7 years) with signs of exacerbation without pneumonia and 30 COPD patients (23 males and 7 females; mean age±SD:69±9 years) with a diagnosis of pneumonia. No difference was determined between the groups in terms of age, gender, presence of diabetes, number of annual exacerbations, and previous antibiotic use. The amount of cigarette smoking (59±36 pack.year versus 38±37 pack.year; p<0.05) was higher and disease duration (COPD) (15±11 years versus 7.7±8 years; p<0.05) was longer in the exacerbation group without pneumonia. Among laboratory findings, whilst there was no difference between the groups in terms of C-reactive protein (CRP), lactate dehydrogenase (LDH) and leukocyte counts, it was observed that forced expiratory volume in 1 second (FEV1) (33.5±10% versus 55±19%; p<0.05 ) was lower in the exacerbation group without pneumonia.Conclusion: It is concluded that COPD patients who were more serious cigarette addicts, had a lower forced expiratory volume in 1 second (FEV1) and a longer disease duration are more prone to exacerbations without pneumonia.

🔖

Cite This Article

DENİZ, S., ÖZHAN, M. H. (2014). Infective Exacerbations of Chronic Obstructive Pulmonary Disease with or without Pneumonia. Solunum, Cilt: 16 - Sayı: 1, 31–35. https://ajindex.com/articles/314295

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) - why and what? Clin Respir J 2012; 6: 208-14. [CrossRef] Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442. [CrossRef] Loddenkemper R, Gibson GJ, Sibille Y. The burden of lung disease in Europe: why a European white book on lung disease? Eur Respir J 2003; 22: 869. [CrossRef] Ornek T, Tor M, Altın R, Atalay F, Geredeli E, Soylu O, et al. Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. Int J Med Sci 2012; 9: 285-90. [CrossRef] Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52. [CrossRef] Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009; 4: 233-43. [CrossRef] Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic ob- structive pulmonary disease. N Engl J Med 2008; 359: 2355-65. [CrossRef] Sethi S, Wrona C, Grant BJ, Murphy TF. Strain-specific immune response to haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 448-53. [CrossRef] Wouters EF. The burden of COPD in the netherlands: results from the confronting COPD survey. Respir Med 2003; 97: 51-59. [CrossRef] Dev D, Wallace E, Sankaran R, Cunniffe J, Govan JR, Wathen CG, et al. Value of C- reactive protein measurements in exacerbations of chronic obstructıve pulmonary disease. Respir Med 1998; 92: 664-7. [CrossRef] Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary dis- ease. N Engl J Med 2010; 363: 1128-38. [CrossRef] Pujades-Rodríguez M, McKeever T, Lewis S, Whyatt D, Britton J, Venn A. Effect of traffic pollution on respiratory and allergic disease in adults: cross-sectional and longitudinal analyses. BMC Pulm Med 2009; 9: 42. [CrossRef] Chabot F, Gomez E, Guillaumot A, Kheir A, Chaouat A. Acute exacerba- tions of chronic obstructive pulmonary disease. Presse Med 2009; 38: 485-95. [CrossRef] Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-